These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The direction of end-stage renal disease reimbursement in the United States. Lockridge RS Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614 [TBL] [Abstract][Full Text] [Related]
7. Medicare program; clarification of resumption of entitlement rules for Medicare patients with end-stage renal disease (ESRD)--HCFA. Final rule. Fed Regist; 1995 May; 60(88 Pt 1):22533-5. PubMed ID: 10142805 [TBL] [Abstract][Full Text] [Related]
9. Medicare survey of the kidney transplant unit: are you prepared? Payne GM; Bell J Nephrol Nurs J; 2005; 32(1):55-8. PubMed ID: 15787084 [TBL] [Abstract][Full Text] [Related]
10. Bundled payment for ESRD--including ESAs in Medicare's dialysis package. Iglehart JK N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538 [No Abstract] [Full Text] [Related]
11. Special treatment--the story of Medicare's ESRD entitlement. Rettig RA N Engl J Med; 2011 Feb; 364(7):596-8. PubMed ID: 21323539 [No Abstract] [Full Text] [Related]
12. Current status of end-stage renal disease care in South Asia. Jha V Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871 [TBL] [Abstract][Full Text] [Related]
13. Dialysis outcomes in works. HCFA may set quality, practice guidelines for ESRD program. Gardner J Mod Healthc; 1997 Feb; 27(5):64-5. PubMed ID: 10164704 [No Abstract] [Full Text] [Related]
14. Unequal access to cadaveric kidney transplantation in California based on insurance status. Thamer M; Henderson SC; Ray NF; Rinehart CS; Greer JW; Danovitch GM Health Serv Res; 1999 Oct; 34(4):879-900. PubMed ID: 10536975 [TBL] [Abstract][Full Text] [Related]
15. Potential impact of Medicare Part D in the end-stage renal disease population. St Peter WL Adv Chronic Kidney Dis; 2008 Apr; 15(2):140-6. PubMed ID: 18334238 [TBL] [Abstract][Full Text] [Related]
16. Duration of end-stage renal disease and kidney transplant outcome. Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892 [TBL] [Abstract][Full Text] [Related]
17. Demographics of the Medicare end-stage renal disease population and populations receiving a functioning graft 1992. Cole DL Med Interface; 1996 Feb; 9(2):42-3. PubMed ID: 10154837 [No Abstract] [Full Text] [Related]
18. The state of kidney transplantation in the United States. Wolfe R Semin Dial; 2005; 18(6):453-5. PubMed ID: 16398704 [TBL] [Abstract][Full Text] [Related]
19. Challenges and directions for Medicare ESRD payment policy. Ray NF; Ross M Semin Nephrol; 2000 Nov; 20(6):565-76. PubMed ID: 11111858 [TBL] [Abstract][Full Text] [Related]
20. The financial implications for Medicare of greater use of peritoneal dialysis. Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]